CTRI/2022/09/045942尚未招募3 期
Azithromycin as an immunomodulator in children with Acute respiratory distress syndrome-Randomized double blinded placebo controlled trial
ARAVINDHAN M0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Mechanically ventilated children (1 month - 18 years) of age admitted
- •with acute respiratory distress syndrome
排除标准
- •1)Children receiving Azithromycin as a part of treatment
- •2)Known Allergic reaction to Azithromycin
- •3)Patients with significant jaundice (Direct bilirubin >1.5mg/dl)
- •4)QT prolongation >450 milli-seconds/ abnormal heart rhythm
研究者
相似试验
进行中（未招募）
不适用
The role of azithromycin in patients with recurrent pneumonia and immunodeficiencyPediatric patients with recurrent pneumonia and MBL deficiency.MedDRA version: 15.1Level: PTClassification code 10061598Term: ImmunodeficiencySystem Organ Class: 10021428 - Immune system disordersMedDRA version: 15.1Level: LLTClassification code 10010120Term: Community acquired pneumoniaSystem Organ Class: 100000004862EUCTR2012-001766-15-ESFundación Pública Andaluza para la Gestion de la Investigación en Salud de Sevilla
招募中
不适用
se of azithromycin( an antibiotic) for duration of three months to control symptoms of asthma in children whose symptoms arenot controlled.CTRI/2019/06/019727Jagat Jeevan ghimire
尚未招募
3 期
Role of Azithromycin in children with acute exacerbation of asthmaCTRI/2020/10/028478I
进行中（未招募）
4 期
A clinical trial to study the effect of Azithromycin on Chronic Periodontitis patientsCTRI/2017/12/011015Dr Divija Pelapudi
招募中
2 期
Azithromycin for Critical Asthma - PediatricsCritical IllnessPediatric AsthmaNCT06223828Johns Hopkins All Children's Hospital100